UTHR

As of 2026-09-10, UTHR scores 46out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. UTHR trades at $503.86, within its fair-value band.

UTHR scores 46 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 46. Its strongest factor is value at 67 (strong), where it screens cheap on the model's valuation inputs, followed by sentiment at 52. The weakest is momentum at 32, where price trend is the soft spot. Among Healthcare stocks it sits in the lower 48% of Healthcare names by composite.

On valuation, UTHR is priced around the middle of its recent range. The blended composite before the macro overlay was 47. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on UTHR, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where UTHR sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for UTHR runs $432.13–$579.45. Current price $503.86 sits within its fair-value band. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.